이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

NeueHealth 과거 수익 실적

과거 기준 확인 0/6

NeueHealth의 수입은 연평균 -31%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.6%의 비율로 증가했습니다. 매출은 연평균 14.5%의 비율로 감소해 왔습니다.

주요 정보

-25.4%

수익 성장률

14.7%

EPS 성장률

Healthcare 산업 성장	8.5%
매출 성장률	-20.2%
자기자본 수익률	n/a
순이익	-47.9%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Bright Health narrows footprint to only offer Medicare Advantage in California, Florida

Oct 11

Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report

Aug 13

Bright Health Group Takes Cost Actions To Effect Turnaround

Jul 21

Bright Health Group: Examining A Dumpster Fire

Jan 04

수익 및 비용 분석

NeueHealth 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

NYSE:NEUE 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	1,033	-495	302
31 Mar 24	1,105	-510	302
31 Dec 23	1,161	-563	315
30 Sep 23	2,756	-1,078	615
30 Jun 23	1,020	-407	328
31 Mar 23	871	-447	337
31 Dec 22	751	-521	354
30 Sep 22	-1,031	-373	9
30 Jun 22	-145	-513	233
31 Mar 22	819	-450	415
31 Dec 21	1,513	-330	527
30 Sep 21	3,427	-534	924
30 Jun 21	2,700	-293	712
31 Mar 21	1,883	-266	539
31 Dec 20	515	-161	221
31 Dec 19	281	-125	180
31 Dec 18	131	-63	96

양질의 수익: NEUE 은(는) 현재 수익성이 없습니다.

이익 마진 증가: NEUE 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: NEUE 은(는) 수익성이 없으며 지난 5년 동안 연간 31% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 NEUE 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: NEUE 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare 업계( 15.1% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: NEUE 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

NeueHealth 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Second quarter 2024 earnings released: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023)

NeueHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024

First quarter 2024 earnings released: US$2.31 loss per share (vs US$9.04 loss in 1Q 2023)

NeueHealth, Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: US$70.72 loss per share (vs US$98.28 loss in FY 2022)

NeueHealth, Inc. to Report Q4, 2023 Results on Mar 06, 2024

Recent updates

Insufficient new directors

Second quarter 2024 earnings released: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023)

NeueHealth, Inc. Updates Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024

New major risk - Financial position

NeueHealth, Inc. announced that it has received $150 million in funding

New minor risk - Shareholder dilution

NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024

First quarter 2024 earnings released: US$2.31 loss per share (vs US$9.04 loss in 1Q 2023)

NeueHealth, Inc. to Report Q1, 2024 Results on May 08, 2024

NeueHealth, Inc., Annual General Meeting, May 02, 2024

Vice Chairman recently sold US$59k worth of stock

New minor risk - Shareholder dilution

New major risk - Negative shareholders equity

Full year 2023 earnings released: US$70.72 loss per share (vs US$98.28 loss in FY 2022)

NeueHealth, Inc. Provides Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q4, 2023 Results on Mar 06, 2024

Third quarter 2023 earnings released: US$72.52 loss per share (vs US$40.11 loss in 3Q 2022)

Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023

New major risk - Revenue and earnings growth

Bright Health Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Bright Health Group, Inc. Announces Leaving of Jeff Cook as Chief Operating Officer, Effective October 13, 2023

Consensus EPS estimates upgraded to US$51.32 loss

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Revises Its Financial Outlook for 2023

Bright Health Group, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Price target increased by 47% to US$200

Florence Labs, Inc. acquired Zipnosis, Inc. from Bright Health Group, Inc. (NYSE:BHG).

Price target decreased by 14% to US$1.70

Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Bright Health Group Announces Chief Financial Officer Changes

Vice Chairman recently sold US$158k worth of stock

Price target decreased by 24% to US$1.50

Consensus EPS estimates fall by 14%

Full year 2022 earnings released: US$1.23 loss per share (vs US$3.02 loss in FY 2021)

Bright Health Group, Inc. to Report Q4, 2022 Results on Mar 01, 2023

Bright Health Group: Stock Price Has Been Too Heavily Beaten Down

Bright Health Group expects FY23 revenue to be below consensus

Independent Director recently bought US$248k worth of stock

Bright Health Group Receives Continued Listing Standard Notice from NYSE

Bright Health receives non-compliance notice from NYSE

Independent Lead Director recently bought US$294k worth of stock

Price target decreased to US$2.07

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Reports Goodwill Impairment for the Three Months Ended September 30, 2022

Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance

Bright Health Group, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Bright Health Group, Inc. announced that it has received $175 million in funding from a group of investors

Bright Health Group, Inc. Provides Revenue Guidance for the Year 2023

Bright Health narrows footprint to only offer Medicare Advantage in California, Florida

Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Provides Revenue Guidance for the Full Year 2022

Bright Health Group, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Bright Health Group Takes Cost Actions To Effect Turnaround

Price target decreased to US$2.76

Bright Health Group, Inc.(NYSE:BHG) dropped from Russell 2000 Growth Index

Bright Health Group Expands Executive Team as It Drives Performance in Scaled Businesses

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Bright Health Group, Inc. to Report Q1, 2022 Results on May 04, 2022

Bright Health Group, Inc., Annual General Meeting, May 13, 2022

Consensus forecasts updated

Bright Health Group, Inc. Provides Earnings Guidance for the Year 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Bright Health Group, Inc. Provides Earnings Guidance for the Year 2022